Profilo
Soraya Bekkali is currently a Director at Vedere Bio II, Inc. She was previously the President, Director & Head-R&D at Gyroscope Therapeutics Ltd., the Chief Medical Officer at Fovea Pharmaceuticals SA, and the Chief Medical Officer & Senior Vice President at Lysogene SA. Bekkali received an undergraduate degree from Sorbonne Université.
Posizioni attive di Soraya Bekkali
| Società | Posizione | Inizio |
|---|---|---|
Vedere Bio II, Inc.
Vedere Bio II, Inc. Miscellaneous Commercial ServicesCommercial Services Develops ocular gene therapy | Direttore/Membro del Consiglio | - |
Precedenti posizioni note di Soraya Bekkali
| Società | Posizione | Fine |
|---|---|---|
Gyroscope Therapeutics Ltd.
Gyroscope Therapeutics Ltd. BiotechnologyHealth Technology Develops gene therapies and medicines for eye diseases | Presidente | 01/07/2019 |
| LYSOGENE | Direttore Tecnico/Scientifico/R&S | - |
Fovea Pharmaceuticals SA
Fovea Pharmaceuticals SA Pharmaceuticals: MajorHealth Technology Develops and commercializes drugs for the treatment of ocular diseases | Direttore Tecnico/Scientifico/R&S | - |
Formazione di Soraya Bekkali
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 5 |
|---|---|
Fovea Pharmaceuticals SA
Fovea Pharmaceuticals SA Pharmaceuticals: MajorHealth Technology Develops and commercializes drugs for the treatment of ocular diseases | Health Technology |
Sorbonne Université
Sorbonne Université Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Lysogene SA
Lysogene SA BiotechnologyHealth Technology Engages in research and clinical development of gene therapy for neurodegenerative disorders | Health Technology |
Gyroscope Therapeutics Ltd.
Gyroscope Therapeutics Ltd. BiotechnologyHealth Technology Develops gene therapies and medicines for eye diseases | Health Technology |
Vedere Bio II, Inc.
Vedere Bio II, Inc. Miscellaneous Commercial ServicesCommercial Services Develops ocular gene therapy | Commercial Services |
















